A fecal transplant was chosen to prevent graft-versus-host disease.
American and German researchers presented interim results of a clinical trial of donor fecal transplantation to prevent graft-versus-host disease after hematopoietic stem cell transplantation for hematological malignancies. The procedure proved to be quite…